GPCR has been in the news 1500% more than usual
Dec 09, 2025, 9:33 PM
1.24%
What does GPCR do
Structure Therapeutics, a clinical stage biopharmaceutical company based in South San Francisco, focuses on developing oral therapeutics targeting GPCRs for chronic diseases. It went public on February 3, 2023, and employs 111 people.
GPCR has been in the news recently: Structure Therapeutics Inc. (NASDAQ:GPCR) experienced a surge in its share price following positive results from a weight loss drug trial, reflecting strong investor interest. The company also benefits from a growing customer base, contributing to a reported 15% increase in revenue.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.